Addendum: Newly diagnosed papillary craniopharyngioma with BRAF V600E mutation treated with single-agent selective BRAF inhibitor dabrafenib: a case report

Detalles Bibliográficos
Autores principales: Rao, Mayank, Bhattacharjee, Meenakshi, Shepard, Scott, Hsu, Sigmund
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2023
Materias:
Addendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171364/
https://www.ncbi.nlm.nih.gov/pubmed/37163235
http://dx.doi.org/10.18632/oncotarget.28428

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171364/
https://www.ncbi.nlm.nih.gov/pubmed/37163235
http://dx.doi.org/10.18632/oncotarget.28428

Ejemplares similares